» Articles » PMID: 22178934

High Expression of Transient Receptor Potential Channels in Human Breast Cancer Epithelial Cells and Tissues: Correlation with Pathological Parameters

Overview
Date 2011 Dec 20
PMID 22178934
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Transient Receptor Potential (TRP) channels are expressed in many solid tumors. However, their expression in breast cancer remains largely unknown. Here, we investigated the profile expression of 13 TRP channels in human breast ductal adenocarcinoma (hBDA) and performed a correlation between their overexpression and pathological parameters.

Methods: The TRP channels expression was determined by RT-PCR in hBDA tissue, in human breast cancer epithelial (hBCE) primary culture and in MCF-7 cell line. The TRP protein level was evaluated by immunohistochemistry in hBDA tissue samples of 59 patients.

Results: TRPC1, TRPC6, TRPM7, TRPM8, and TRPV6 channels were overexpressed in hBDA compared to the adjacent non-tumoral tissue. Most interestingly, TRPC1, TRPM7 and TRPM8 expression strongly correlated with proliferative parameters (SBR grade, Ki67 proliferation index, and tumor size), and TRPV6 was mainly overexpressed in the invasive breast cancer cells. Using laser capture microdissection, we found that TRPV6 expression was higher in invasive areas, compared to the corresponding non-invasive ones. Moreover, TRPV6 silencing inhibited MDA-MB-231 migration and invasion, and MCF-7 migration.

Conclusion: TRP channels are aberrantly expressed in hBDA, hBCE primary cultures, and cell lines, and associated with pathological parameters. The high expression of TRP channels in tumors suggests the potential of these channels for diagnostic, prognosis and/or therapeutic approaches in human breast ductal adenocarcinoma.

Citing Articles

TRP channels and breast cancer: the role of TRPs in the pathophysiological development.

Zhang Y, Yi Y, Shu Y, Ru X, He S Front Mol Biosci. 2025; 12:1528663.

PMID: 40078961 PMC: 11896876. DOI: 10.3389/fmolb.2025.1528663.


TRPM channels in human cancers: regulatory mechanism and therapeutic prospects.

Liu Q, Hu M, Li S, Zhang X, Zhang R, Lyu H Biomark Res. 2024; 12(1):152.

PMID: 39633507 PMC: 11616203. DOI: 10.1186/s40364-024-00699-2.


STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltration.

Zhang Y, Li J, Feng L, Cheng Y, Shi L, Yang Q Am J Cancer Res. 2024; 14(7):3294-3316.

PMID: 39113874 PMC: 11301302. DOI: 10.62347/EAQW3113.


The odyssey of the TR(i)P journey to the cellular membrane.

Rivera B, Orellana-Serradell O, Servili E, Santos R, Brauchi S, Cerda O Front Cell Dev Biol. 2024; 12:1414935.

PMID: 39108834 PMC: 11300232. DOI: 10.3389/fcell.2024.1414935.


Use of tetraethylammonium (TEA) and Tris loading for blocking TRPM7 channels in intact cells.

Holderby K, Kozak J Front Pharmacol. 2024; 15:1341799.

PMID: 38659572 PMC: 11039802. DOI: 10.3389/fphar.2024.1341799.